Exozymes (NASDAQ:EXOZ - Get Free Report) posted its earnings results on Monday. The company reported ($0.22) EPS for the quarter, Zacks reports.
Exozymes Stock Up 10.9%
EXOZ stock traded up $1.48 during trading hours on Friday, hitting $15.04. The company's stock had a trading volume of 32,132 shares, compared to its average volume of 19,539. Exozymes has a 12 month low of $8.50 and a 12 month high of $23.99. The stock has a 50 day moving average of $12.08.
Exozymes Company Profile
(
Get Free Report)
eXoZymes, Inc is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.
Featured Articles
Before you consider Exozymes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exozymes wasn't on the list.
While Exozymes currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
